𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of etidronate therapy on bone turnover and bone density in mild paget's disease

✍ Scribed by Blumsohn, A.; Naylor, K.E.; Assiri, A.M.A.; Eastell, R.

Book ID
121903993
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
157 KB
Volume
17
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
✍ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients

Biochemical markers of bone turnover in
Biochemical markers of bone turnover in paget's disease of bone
✍ P.D. Delmas πŸ“‚ Article πŸ“… 1999 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 497 KB

Although the measurement of total alkaline phosphatase activity in serum is a valid index to 8ssess the activity of Paget's disease of bone and to monitor treatment efficacy, this marker may lack sensitivity in some cases. Among the various markers of bone formation and resorption that have been dev